- Home
- SYBX vs SNES Comparison
SYBX vs SNES Comparison
Compare SYBX & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYBX | SNES |
|---|---|---|
| Founded | N/A | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2M | 14.5M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | SYBX | SNES |
|---|---|---|
| Price | $1.14 | $2.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 77.3K | 39.2K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,301,000.00 |
| Revenue This Year | N/A | $41.52 |
| Revenue Next Year | N/A | $77.28 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 39.37 |
| 52 Week Low | $0.90 | $1.30 |
| 52 Week High | $1.96 | $6.24 |
Technical Indicators
Market Signals| Indicator | SYBX | SNES |
|---|---|---|
| Relative Strength Index (RSI) | 39.17 | 36.89 |
| Support Level | $1.14 | $2.25 |
| Resistance Level | $1.28 | $2.53 |
| Average True Range (ATR) | 0.07 | 0.19 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 59.26 | 12.50 |
Price Performance
Historical ComparisonAbout SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.